When.com Web Search

  1. Ad

    related to: pfizer ex dividend date 2023 full year 2018

Search results

  1. Results From The WOW.Com Content Network
  2. Down 55%, Is Pfizer a Good Dividend Stock to Buy on the Dip?

    www.aol.com/down-55-pfizer-good-dividend...

    With a lot of new drugs to sell, Pfizer expects adjusted earnings to reach a range between $2.15 and $2.35 per share this year, which is more than it needs to meet a dividend commitment currently ...

  3. 2 Dividend Stocks That Pay More Than 6% That Retirees Can ...

    www.aol.com/finance/2-dividend-stocks-pay-more...

    Two good examples of stocks that pay more than 6% and can still be ideal long-term options for retirees are Pfizer (NYSE: PFE) and Verizon Communications (NYSE: VZ).

  4. Ex-dividend date - Wikipedia

    en.wikipedia.org/wiki/Ex-dividend_date

    The ex-date or ex-dividend date represents the date on or after which a security is traded without a previously declared dividend or distribution. [1] The opening price on the ex-dividend date, in comparison to the previous closing price, can be expected to decrease by the amount of the dividend, although this change may be obscured by other ...

  5. Pfizer Just Confirmed It's a Dividend Investor's Dream Stock

    www.aol.com/pfizer-just-confirmed-dividend...

    The good news on this front, though, is that Pfizer is poised to improve its bottom line and make its dividend even safer. Sure, the big pharma company's earnings fell 11% year over year in Q2.

  6. Is Pfizer the Best Dividend Stock for You? - AOL

    www.aol.com/finance/pfizer-best-dividend-stock...

    In the meantime, Pfizer could see an upward nudge from its specialty care products, which grew sales by 19% year over year in Q1. Management is forecasting full-2024 sales at between $58.5 billion ...

  7. Pfizer - Wikipedia

    en.wikipedia.org/wiki/Pfizer

    The company's largest products by sales are the Pfizer–BioNTech COVID-19 vaccine ($11 billion in 2023 revenues), apixaban ($6 billion in 2023 revenues), a pneumococcal conjugate vaccine ($6 billion in 2023 revenues), palbociclib ($4 billion in 2023 revenues), and tafamidis ($3 billion in 2023 revenues). [1]

  8. S&P 500 Dividend Aristocrats - Wikipedia

    en.wikipedia.org/wiki/S&P_500_Dividend_Aristocrats

    The S&P 500 Dividend Aristocrats is a stock market index composed of the companies in the S&P 500 index that have increased their dividends in each of the past 25 consecutive years. It was launched in May 2005.

  9. Is Pfizer's 5.7% Dividend Yield Worth the Risk? - AOL

    www.aol.com/pfizers-5-7-dividend-yield-110000025...

    Pharmaceutical giant Pfizer (NYSE: PFE) stands out in this context. The company currently offers a mouthwatering 5.7% dividend yield -- the highest among major drug manufacturers and one of the ...